Complications Based Questions: Difference between revisions
Jump to navigation
Jump to search
Aisha Adigun (talk | contribs) |
Aisha Adigun (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Frequently Asked Inpatient Questions}} | {{Frequently Asked Inpatient Questions}} | ||
{{CMG}}: {{AE}} | {{CMG}}: {{AE}} {{Aisha}} | ||
==Complications Based Questions== | ==Complications Based Questions== | ||
====What population is most at risk for severe disease from COVID-19?==== | ====What population is most at risk for severe disease from COVID-19?==== |
Revision as of 21:10, 14 June 2020
Frequently Asked Inpatient Questions Microchapter |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]: Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]
Complications Based Questions
What population is most at risk for severe disease from COVID-19?
- COVID-19 is a new disease and there is limited information regarding risk factors for severe illness. Based on currently available information and clinical expertise, older adults and people of any age who have serious underlying medical conditions might be at higher risk for severe illness from COVID-19.
What risk factors result in severe complications from COVID-19?
- Information on COVID-19 evolves daily. Current known risk factors include but are not limited to underlying chronic conditions such as; lung disease, moderate to severe asthma, cardiac disease with complications, diabetes, or immunocompromising conditions.
What systems other than the Respiratory system can be involved?
- Although research for COVID-19 is still ongoing, scientists have found extra-pulmonary manifestations in several other systems. It is thought that the virus instigates a "cytokine storm" where the body responds massively, leading to widespread cytokine release, cellular, tissue, and organ damage. Extra-pulmonary manifestations include but are not limited to;
- Heart Inflammation
- Neurological manifestations
- Renal disease
- Liver and digestive tract compromise
- Venous thromboembolism.